Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Special Drug Use Investigation of Rivaroxaban in Pediatric Patients With Congenital Heart Disease (CHD) Who Had Undergone the Fontan Procedure

NCT06193863 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT06193863
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06193863 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Special Drug Use Investigation of Rivaroxaban in Pediatric Patients With Congenital Heart Disease (CHD) Who Had Undergone the Fontan Procedure
Lead sponsor
Bayer
Phase
Observational
Overall status
Active, not recruiting
Start date
June 18, 2024
Completion date
December 31, 2026
Enrollment
61 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

children, congenital heart disease, fontan procedure, prevention of venous thromboembolism